ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Four Pivotal Categories To Elevate Your Clinical Vendor Management

  For sponsors ready to improve vendor management, technology platforms with the right framework can help you tighten budget controls, improve data integrity, or foster collaborative vendor relationships.

• Leading eSource Software Company Receives Part 11/Annex 11 Verification

  Uncover how an independent confirmation of compliance opened up new opportunities and is instilling confidence in customers who are integrating the eSource system into their software validation strategy.

• Build Versus Buy: What's The Best Tech Tool For Study Activation?

  In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.

• Securing Sponsor Reimbursement For CRIO Fees

  Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.

• What Universalized Terminology Means For Decentralized Research

  Many DCT stakeholders have attempted to release terminology guides as it relates to their own dealings, however, there had never been a wide range of universalized DCT terms until now. 

• Navigating eCOA Licensing And Localization In Clinical Trials

  eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.

• How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?

  Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?

• 5 Trends To Watch This Year

  Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

• Why Site Training Still Slows Site Activation

  Effective site training relies on clear, accessible, up-to-date materials that reflect real workflows — keeping sites aligned, compliant, and confident throughout the study lifecycle.

• Navigating Biases In Clinical Trial Vendor Selection

  Biases, often hidden, can distort vendor selection decisions. Recognizing and addressing them across individuals and teams leads to more objective, aligned, and successful clinical trial outcomes.